In vitro testing of cyto- and genotoxicity of new porphyrin water-soluble metal derivatives

International Journal of Toxicology

Volumn 26, Issue 6, 2007, Pages 497-502

  Gasparyan, Gennadi ^a,b   Hovhannisyan, Galina ^a   Ghazaryan, Robert ^c   Sahakyan, Lida ^c   Tovmasyan, Artak ^c   Grigoryan, Rusanna ^b   Sarkissyan, Natalia ^b   Haroutiunian, Samvel ^a   Aroutiounian, Rouben ^a  

^a YEREVAN STATE UNIVERSITY   (Armenia)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Armenia)

^c YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

Author keywords

Cytotoxicity; Genotoxicity; In Vitro Testing; Porphyrin Metal Derivatives

Indexed keywords

METALLOPORPHYRIN; SILVER; TRYPAN BLUE; ZINC;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; GENOTOXICITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; KIDNEY CELL; MICRONUCLEUS TEST; NONHUMAN; PROSTATE CARCINOMA; SIMIAN VIRUS 40;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; K562 CELLS; METALLOPORPHYRINS; MICRONUCLEUS TESTS; SOLUBILITY; WATER;

CERCOPITHECUS AETHIOPS; SIMIAN VIRUS 40; TETRA;

EID: 36849089713     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701707056     Document Type: Article

References (37)

1. Asayama, S., N. Kasugai, S. Kubota, S. Nagaoka, and H. Kawakami. 2007. Superoxide dismutase as a target for Fe-porphyrin-induced cell death. J. Inorg. Biochem. 101:261-266.
2. Berg, K. P., K. Selbo, A. Weyergang, A. Dietze, L. Prasmickaite, A. Bonsted, B. O. Engesaeter, E. Angell-Petersen, T. Warloe, N. Frandsen, and A. Hogset. 2005. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J. Microsc. 218(Pt. 2): 133-147.
3. Brown, P. O., and D. Botstein. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21(1 Suppl):33-37.
4. Colombo, P., K. Gunnarson, M. Iatropoulos, and M. Brughera. 2001. Toxicological testing of cytotoxic drugs [review]. Int. J. Oncol. 19:1021-1028.
5. Curry, P. T., M. L. Kropko, J. R. Garvin, R. D. Fiedler, and J. C. Theiss. 1966. In vitro induction of micronuclei and chromosome aberrations by quinolines: Possible mechanisms. Mutat. Res. 352:143-150.
6. Dalyan, Y. B., S. G. Haroutiunian, G. V. Ananyan, V. I. Vardanyan, D. Yu. Lando, V. N. Madakyan, R. K. Kazaryan, L. Messori, P. Orioli, and A. S. Benight. 2001. Interaction of meso-tetra-(4-N-oxyethylpyridyl) porphyrin, its 3-N analog and their metallocomplexes with duplex DNA. J. Biomol. Struct. Dyn. 18:677-687.
7. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng. 1998. Photodynamic therapy. J. Natl. Cancer I. 90:889-905.
8. El-Far, M., and N. Pimstone. 1984. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: Uroporphyrin I superior to hematoporphyrin derivative. Prog. Clin. Biol. Res. 170:661-672.
9. Fang, J., T. Sawa, T. Akaike, T. Akuta, S. K. Sahoo, G. Khaled, A. Hamada, and H. Maeda. 2003. In vivo antitumor activity of pegylated zinc protoporphyrin. Targeted inhibition of heme oxygenase in solid tumor. Cancer Res. 63:3567-3574.
10. Fenech, M. 1993. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. 285:35-44.
11. Fenech, M. 1997. The advantages and disadvantages of cytokinesis-block micronucleus method. Mutat. Res. 392:11-18.
12. Fenech, M. 2000. The in vitro micronucleus technique. Mutat. Res. 455:81-95.
13. Ghazaryan, R. K., L. A. Sahakyan, A. G. Tovmasyan, G. V. Gyulkhandanyan, and S. K. Yericyan. 2006a. Metallocomplexes of meso-tetra-pyridylporphyrins' derivatives with simultaneously fungicide and growth stimulating activities. Patent of the Republic of Armenia, no. 1716 A2.
14. Ghazaryan, R. K., L. A. Sahakyan, and A. G. Tovmasyan. 2006b. Derivatives of Meso-tetra-4-N-pyridylporphyne and their metallocomplexes. Patent of the Republic of Armenia, no. 1714 A2.
15. Ghazaryan, R. K., L. A. Sahakyan, A. G. Tovmasyan, and G. V. Gyulkhandanyan. 2006c. Silver complex of meso-tetra-(4-N-oxyethylpyridyl) porphyne possessing simultaneously fungicide and bactericide activities. Patent of the Republic of Armenia, no. 1715 A2.
16. Grand, C. L., H. Han, R. M. Munoz, S. Weitman, D. D. Von Hoff, L. H. Hurley, and D. J. Bearrs. 2002. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol. Cancer Ther. 1:565-573.
17. GSH Rev. 1. 2005. Globally Harmonized System of Classification and Labelling of Chemicals, 1st edited edition.
18. Heddle, J. A. 1973. A rapid in vivo test for chromosomal damage. Mutat. Res. 18:187-190.
19. Hovhannisyan, G., S. Haroutiunian, M. Margaryan, R. Ghazaryan, and R. Aroutiounian. 2005. DNA damage induced by new porphyrins of different chemical structure. Korean J. Environ. Biol. 23:379-382.
20. Jori, G. 2006. Photodynamic therapy of microbial infections: state of the art and perspectives. J. Environ. Pathol. Toxicol. Oncol. 25:505-519.
21. Lambrechts, S. A., M. C. Aalders, F. D. Verbraak, J. W. Lagerberg, J. B. Dankert, and J. J. Schuitmaker. 2005. Effect of albumin on the photodynamic inactivation of microorganisms by a cationic porphyrin. J. Photochem. Photobiol. B 79:51-57.
22. Liebsch, M., and H. Spielmann. 1995. BALB/c 3T3 cytotoxicity test. Methods Mol. Biol. 43:177-187.
23. Masters, J. R. W. 2000. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell. Biol. 1:233-236.
24. Ohse, T., S. Nagaoka, Y. Arakava, H. Kavakami, and K. Nakamura. 2001. Cell death by reactive oxygen species generated from water-soluble cationic metalloporphyrins as superoxide dismutase mimics. J. Inorg. Biochem. 85:201-208.
25. Parry, J. M. 1998. A proposal for a new OECD guideline for the in vitro micronucleus test. http://www.swan.ac.uk/cget/ejgt/article MN UKEMS Protocol.htm.
26. Perou, C. M., S. S. Jeffrey, M. van de Rijn, C. A. Rees, M. B. Eisen, D. T. Ross, A. Pergamenschikov, C. F. Williams, S. X. Zhu, J. C. Lee, D. Lashkari, D. Shalon, P. O. Brown, and D. Botstein. 1999. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. U. S. A. 96:9212-9217.
27. Ross, D. T., U. Scherf, M. B. Eisen, C. M. Perou, C. Rees, P. Spellman, V. Iyer, S. S. Jeffrey, M. Van de Rijn, M. Waltham, A. Pergamenschikov, J. C. Lee, D. Lashkari, D. Shalon, T. G. Myers, J. N. Weinstein, D. Botstein, and P. O. Brown. 2000. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24:227-235.
28. Sahoo, S. K., T. Sawa, J. Fang, S. Tanaka, Y. Miyamoto, T. Akaike, and H. Maeda. 2002. Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity. Bioconjug. Chem. 13:1031-1038.
29. Stojiljkovic, I., and G. G. Churchward. 2000. Non-iron metalloporphyrins and methods of use. United States Patent, no. 6066628.
30. Stojiljkovic, I., B. D. Evavold, and V. Kumar. 2001. Antimicrobial properties of porphyrins. Expert Opin. Inv. Drug. 10:309-320.
31. Vicente, M. G. 2001. Porphyrin-based sensitizers in the detection and treatment of cancer: recent progress. Curr. Med. Chem. Anticancer Agents 1:175-194.
32. Vogel, R., G. Laschinski, H. Spielman, W. Ehrlich, B. Drevenstedt, J. Klosa, and H. Kröger. 1991. In vitro studies on genotoxicity and cytotoxicity of the anticancer drugs cisplatin and cofplaton, a caffeine-8-ether plus cisplatinum compound. Mutat. Res. 264:225-230.
33. Vzorov, A. N., D. W. Dixon, J. S. Trommel, L. G. Marzilli, and R. W. Compans. 2002. Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrob. Agents Chemother. 46:3917-3925.
34. Wang, Y., Q. He, B. W. Sun, C. Che, and J. Chiu. 2007. Cellular pharmacological properties of gold(III)porphyrin 1a, a potent anticancer drug lead. Eur. J. Pharmacol. 554:113-122.
35. Wistuba, I. I., C. Behrens, S. Milchgrub, S. Syed, M. Ahmadian, A. K. Virmani, V. Kurvari, T. H. Cunningham, R. Ashfaq, J. D. Minna, and A. F. Gazdar. 1998. Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin. Cancer Res. 4:2931-2938.
36. Wistuba, I. I., D. Bryant, C. Behrens, S. Milchgrub, A. K. Virmani, R. Ashfaq, J. D. Minna, and A. F. Gazdar. 1999. Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin. Cancer Res. 5:991-1000.
37. Yang, G., X. Nguyen, J. Ou, P. Rekulapelli, D. K. Stevenson, and P. A. Dennery. 2001. Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis. Blood. 97:1306-1313.